Immunomodulation as a potent COVID-19 pharmacotherapy: past,
present and future
Decsa M. Hertanto MD1,2; Henry Sutanto MD,
PhD3; Citrawati D.K. Wungu MD,
PhD4,5
1Department of Internal Medicine, Airlangga
University, Surabaya, Indonesia
2Department of Internal Medicine, Soetomo General
Hospital, Surabaya, Indonesia
3Department of Cardiology, CARIM School for
Cardiovascular Diseases, Maastricht University, Maastricht, The
Netherlands
4Department of Physiology and Medical Biochemistry,
Airlangga University, Surabaya, Indonesia
5Institute of Tropical Disease, Airlangga University,
Surabaya, Indonesia
Running Title: Immunomodulation in COVID-19
Word Count: 2000 (excluding abstract, references and figure
legends)
Funding: None
Author contribution: All authors have significantly contributed
to the conception and design, or acquisition of data; All authors have
involved in drafting the manuscript or revising it critically; and they
have given their final approval of the version to be published.
Conflict of interest: None